Hi-Tech Pharmaceuticals Indicted For Online “Generic” Drug Enterprise
This article was originally published in The Tan Sheet
Executive Summary
A federal grand jury has indicted Hi-Tech Pharmaceuticals and 11 individuals on multiple felony charges for allegedly selling adulterated and unapproved new drugs via the Internet, the Drug Enforcement Agency announced Sept. 20
You may also be interested in...
Hi-Tech Hunts Growth As FTC Picks Up Scent On Disputed Weight Loss Claims
FTC asks a federal court to re-instate a contempt order stemming from Hi-Tech Pharmaceuticals’ misleading claims for weight loss supplements that an appellate court overturned. Hi-Tech, meanwhile, argues for recusal of the judge who found the firm in contempt and ordered two executives to jail.
Hi-Tech Hunts Growth As FTC Picks Up Scent On Disputed Weight Loss Claims
FTC asks a federal court to re-instate a contempt order stemming from Hi-Tech Pharmaceuticals’ misleading claims for weight loss supplements that an appellate court overturned. Hi-Tech, meanwhile, argues for recusal of the judge who found the firm in contempt and ordered two executives to jail.
Hi-Tech CEO Could Face Jail For Violating Court Order To Recall Weight Loss Products
A federal judge soon will decide whether Hi-Tech Pharmaceuticals CEO Jared Wheat goes to jail for failing to recall weight loss products marketed with false claims. Wheat has a history of run-ins with FDA, FTC and DEA for marketing supplements adulterated with drugs and making false claims for products.